These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27252258)

  • 21. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
    PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease.
    Leffler J; Martin M; Gullstrand B; Tydén H; Lood C; Truedsson L; Bengtsson AA; Blom AM
    J Immunol; 2012 Apr; 188(7):3522-31. PubMed ID: 22345666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory testing for the diagnosis, evaluation, and management of systemic lupus erythematosus: Still more questions for the next generations: A Tribute and Thanks and in Memory of my mentor: Henry G. Kunkel.
    Schur PH
    Clin Immunol; 2016 Nov; 172():117-121. PubMed ID: 27506962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a new fluorescence immunoassay to detect anti-dsDNA antibodies is more correlated with disease activity and complement than the ELISA method in SLE patients.
    Chen CY; Tseng HM; Chen LC; Tsao CH; Kuo ML; Ou LS; Huang JL
    Lupus; 2003; 12(4):266-73. PubMed ID: 12729049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
    de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
    Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric detection of autoantibodies in systemic lupus erythematosus.
    Budde P; Zucht HD; Vordenbäumen S; Goehler H; Fischer-Betz R; Gamer M; Marquart K; Rengers P; Richter J; Lueking A; Schulz-Knappe P; Schneider M
    Lupus; 2016 Jul; 25(8):812-22. PubMed ID: 27252257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosus compared with adult onset systemic lupus erythematosus.
    Pisoni CN; Muñoz SA; Carrizo C; Cosatti M; Álvarez A; Dubinsky D; Bresan E; Russo R; Borgia E; García M; Sansinanea P; Basta MC; D'Amico MA; Barreira JC; Lancioni E; Soriano E; Cunto Cd; Beron A; Eimon A
    Reumatol Clin; 2015; 11(2):73-7. PubMed ID: 24816340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and risk stratification in patients with anti-RNP autoimmunity.
    Carpintero MF; Martinez L; Fernandez I; Romero AC; Mejia C; Zang YJ; Hoffman RW; Greidinger EL
    Lupus; 2015 Sep; 24(10):1057-66. PubMed ID: 25736140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus.
    Montiel JL; Monsiváis-Urenda A; Figueroa-Vega N; Moctezuma JF; Burgos-Vargas R; González-Amaro R; Rosenstein Y
    Scand J Rheumatol; 2010; 39(1):50-7. PubMed ID: 20132071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus.
    Utz PJ
    Lupus; 2004; 13(5):304-11. PubMed ID: 15230283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of autoantibodies in pediatric-onset systemic lupus erythematosus and their relationship with disease-associated manifestations.
    Gilliam BE; Ombrello AK; Burlingame RW; Pepmueller PH; Moore TL
    Semin Arthritis Rheum; 2012 Jun; 41(6):840-8. PubMed ID: 22177108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus.
    Eriksson C; Rantapää-Dahlqvist S
    Lupus; 2014 Jun; 23(7):691-6. PubMed ID: 24531079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
    Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
    Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microvascular findings in patients with systemic lupus erythematosus assessed by fundus photography with fluorescein angiography.
    Lee JH; Kim SS; Kim GT
    Clin Exp Rheumatol; 2013; 31(6):871-6. PubMed ID: 24021339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased binding of circulating systemic lupus erythematosus autoantibodies to recombinant interferon alpha 2b.
    Khan WA; Qureshi JA
    APMIS; 2015 Dec; 123(12):1016-24. PubMed ID: 26547367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosus.
    Touma Z; Gladman DD; Tulloch-Reid D; Toloza SM; Ibañez D; Fortin PR; Urowitz MB
    Clin Exp Rheumatol; 2010; 28(4):525-31. PubMed ID: 20659409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study.
    Compagno M; Gullstrand B; Jacobsen S; Eilertsen GØ; Nilsson JÅ; Lood C; Jönsen A; Truedsson L; Sturfelt G; Bengtsson AA
    Arthritis Res Ther; 2016 Feb; 18():44. PubMed ID: 26860519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia.
    Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P
    J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus.
    Manzi S; Ahearn JM; Salmon J
    Lupus; 2004; 13(5):298-303. PubMed ID: 15230282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.